Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

TransCanna Holdings Inc. is a cannabis branding, transportation and distribution company in California that assists cannabis cultivators and manufacturers in getting recognized by end-users and consumers.

Each Warrant entitles the holder thereof upon exercise, together with payment of the exercise price of $3.00 before the time of expiry subject to acceleration to acquire one common share.

Transcanna Holdings Inc. - Common Shares

Tree of Knowledge International Corp. (TOKI) is a public company that delivers pathways to innovative, science-based health and wellness solutions. The Company is a leader in pain management, spanning from seed to patient. Built upon an extensive network of scientific and medical research, TOK is an advanced leader in the development, processing, and distribution of focused products and treatments for pain relief. Tree of Knowledge spans the globe with its multidisciplinary pain clinics, research partners, consumer CBD products, and education and advocacy programs – all working in harmony to bring health and wellness to the world while creating value for shareholders and partners.

True Leaf Brands Inc. (“True Leaf”) (CSE: MJ) (OTC Pink: TRLFD) (FSE: TLAA) is a Licensed Producer of cannabis preparing to launch a program to provide seed-to-shelf solutions for micro-cultivators and small-scale producers. The program will operate from the company’s 40-acre True Leaf Campus facility in Lumby, B.C., Canada, and will provide a full suite of in-house production, processing, and packaging services to the burgeoning craft cannabis community.

To learn more, please visit our website at www.trueleafbrands.com.

Trulieve Cannabis Corp. - Subordinate Voting Shares

Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.

Investor Note: In addition to the 549,195.96 Subordinate Voting Shares that are listed and trading, there are 73,330,823 shares reserved for issuance pursuant to the conversion rights attached to the Super Voting Shares and Multiple Voting Shares that are issued and outstanding but not listed. The total number of issued  shares assuming all are converted into the listed class would be 73,880,019.

Trulieve Cannabis Corp. - Subordinate Voting Shares

The Company is a pharmaceutical company focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. The Company intends to do this through the development of compounds with known activity and/or safety profiles. The Company’s lead program is designed to address neurological disorders through the therapeutic dosing of synthetic psilocybin. The Company is currently evaluating potential lead indications for its psilocybin-for-neurology program, which it refers to as its PFN™ program, including fibromyalgia and Prader-Willi Syndrome. In addition to its PFN™ program, the Company is developing razoxane for the treatment of soft-tissue sarcomas. The Company continues to evaluate potential additional indications for its existing programs, as well as other drug candidates with known activity and/or safety profiles that may have utility in the treatment of rare diseases or other diseases with high unmet medical needs.

Valeo Pharma is a Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respiratory diseases, Neurodegenerative Diseases, Oncology and Hospital Specialty Products. Headquartered in Kirkland, Quebec Valeo Pharma has all the required capabilities and the full infrastructure to register and properly manage its growing product portfolio through all stages of commercialization. For more information, please visit www.valeopharma.com and follow us on LinkedIn and Twitter.

Valeo Pharma Inc. - Common Shares

Valeo Pharma is a specialty pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada. With a focus on neurodegenerative diseases, woman’s health and oncology, Valeo Pharma has a growing portfolio of innovative products and the proper infrastructure to manage these products through all stages of commercialization.  Headquartered in Kirkland, Quebec, Valeo Pharma has all internal capabilities to register and market health care solutions for Canadian patients. For more information, please visit www.valeopharma.com

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2021-10-19_MJBizFinance_Website.jpg

MJBizFinance Forum

Tuesday, October 19, 2021 -
12:00pm to 8:00pm

Advertisement

Publicité